| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/27/2005 | CN1198639C Immune enhancing compositions |
| 04/27/2005 | CN1198622C Steroidal saponins for treating alzheimer's disease and derivatives thereof |
| 04/27/2005 | CN1198616C Oral formulations for anti-tumor compounds |
| 04/27/2005 | CN1198614C Method for treating inflammatory diseases using pADPRT inhibitors |
| 04/27/2005 | CN1198613C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing the same |
| 04/27/2005 | CN1198608C Therapeutic and dietary compsns. containing essential fatty acids and bioactive disulphides |
| 04/27/2005 | CN1198607C Composition for treating or preventing glomerulopathy |
| 04/27/2005 | CN1198605C Compound with 5-HT1A activity useful for treating disorders of outer retina |
| 04/27/2005 | CN1198597C Stable pharmaceutical formulation comprising HMC-CoA reductase inhibitor |
| 04/27/2005 | CN1198591C Bioenhanced formulations comprising eprosartan in oral dosage form |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/26/2005 | US6884869 Pentapeptide compounds and uses related thereto |
| 04/26/2005 | US6884868 Cyclic hexapeptides having antibiotic activity |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884803 Phenylalkynes |
| 04/26/2005 | US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884796 Useful for relieving infertility in females and males |
| 04/26/2005 | US6884795 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 04/26/2005 | US6884768 Using taurine compound; adjust bioavailability; prevent, suppression damage to intestine mucous membrane |
| 04/26/2005 | US6884595 Test tumor cell modulation; analyzing chromosomes |
| 04/26/2005 | US6884437 Administration form comprising an acid-labile active compound |
| 04/26/2005 | US6884434 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
| 04/26/2005 | US6884425 Adapted for improving skin ageing and/or photoageing signs, which cutaneous signs are directly a result of a chronic micro-inflammatory process induced by repeated UV exposures |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/26/2005 | CA2244134C Diphenyl stilbenes as prodrugs to cox-2 inhibitors |
| 04/26/2005 | CA2239053C Diphenyl pyridyl ethane derivatives as pde iv inhibitors |
| 04/26/2005 | CA2053253C New aryl-and heteroarylethenylene derivatives and process for their preparation |
| 04/21/2005 | WO2005035772A1 Simplified method for producing therapeutic viral vectors which are free of marker genes in their therapeutically suitable form |
| 04/21/2005 | WO2005035751A1 Method of quickly and efficiently selecting high-functioning protein, high-functioning protein thus obtained, method of producing the same and method of using the same |
| 04/21/2005 | WO2005035583A1 Antibody composition specifically binding to il-5 receptor |
| 04/21/2005 | WO2005035571A1 Novel glycoprotein and medicinal composition containing the same |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035516A1 Novel fused heterocyclic compound and use thereof |
| 04/21/2005 | WO2005035512A1 Thiadiazoline derivatives |
| 04/21/2005 | WO2005035506A1 Novel indazole derivative |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035501A1 Novel olefin derivative |
| 04/21/2005 | WO2005035471A1 Ether derivative |
| 04/21/2005 | WO2005035004A1 COMPOSITION FOR INHIBITING FUNCTION OF HUMAN Flt3 |
| 04/21/2005 | WO2005034959A1 USE OF 2-METHYLENE-19-NOR-20(S)-1a,25-DIHYDROXYVITAMIN D3 TO INCREASE THE LIFE EXPECTANCY OF HUMAN BEINGS |
| 04/21/2005 | WO2005034944A1 Combinations of indole compounds and alkylating agents for the treatment of cancer |
| 04/21/2005 | WO2005034938A1 Collagen productin enhancer and production process and use thereof |
| 04/21/2005 | WO2005034912A2 Ferromagnetic particles and methods |
| 04/21/2005 | WO2005020882A3 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 04/21/2005 | WO2004108119A3 Use of atp or derivatives in medicine |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | WO2003061584A3 Novel substituted benzimidazole dosage forms and method of using same |
| 04/21/2005 | WO2003049673A3 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 04/21/2005 | WO2002099053A3 Slc22as as modifiers of the p53 pathway and methods of use |
| 04/21/2005 | WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 04/21/2005 | WO2002057425A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/21/2005 | US20050086711 Transgenic animals and methods for screening for anti-amyloidogenic agents and agents for treating neurodegenerative disease |
| 04/21/2005 | US20050085860 Transdermal/transmucosal preparations for electroporation |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents |
| 04/21/2005 | US20050085637 Pyrimidine compounds |
| 04/21/2005 | US20050085553 Remedies for mild recognition deflict |
| 04/21/2005 | US20050085548 Administering mixture of arginine and reductase inhibitase; therapy for endothelial cell diseases; hypotensive agents; cardiovascular disorders brain disorders |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085535 Lipase inhibiting polymers |
| 04/21/2005 | US20050085532 Prevention, therapy of central nervous system disorders ; antidepressants; anxiolytic agents; eating and sleep disorders; Alzheimer's disease; strokes; schizophrenia; incontinence; gastrointestinal disorders; cardiovascular disorders |
| 04/21/2005 | US20050085530 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 04/21/2005 | US20050085520 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
| 04/21/2005 | US20050085517 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/21/2005 | US20050085515 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 04/21/2005 | US20050085513 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |
| 04/21/2005 | US20050085508 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents |
| 04/21/2005 | US20050085505 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 04/21/2005 | US20050085503 used for detecting diseases where N-acetylated alpha -linked acidic dipeptidase (NAALADase) levels are altered, effecting neuronal activity, effecting TGF- beta activity, inhibiting angiogenesis, and treating glutamate abnormalities, cancer, pain |
| 04/21/2005 | US20050085487 Heterocyclic compounds |
| 04/21/2005 | US20050085480 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 04/21/2005 | US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 04/21/2005 | US20050085471 Using 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-one; enzyme inhibitors; antithrombotic agents ; restenosis; atherosclerosis; antihistamines; chronic obsessive pulminary disease; autoimmune diseases; anticancer agents; antiinflammatory agents |
| 04/21/2005 | US20050085469 Fused bicyclic pyrimidine derivatives |
| 04/21/2005 | US20050085461 Benzenesulfonamide derivatives |
| 04/21/2005 | US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease |
| 04/21/2005 | US20050085458 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/21/2005 | US20050085448 Viricides against herpes virus; autoimmune disease; antitumor agents |
| 04/21/2005 | US20050085440 Formulation |
| 04/21/2005 | US20050085424 Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof |
| 04/21/2005 | US20050085421 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 04/21/2005 | US20050085414 Novel medical use for tachykinin antagonists |
| 04/21/2005 | US20050085408 Drugs ameliorating hypo-hdl cholesterolemia |
| 04/21/2005 | US20050084966 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/21/2005 | US20050084964 Progenitor cells which can be differentiated into hepatic, pancreatic and/or salivary gland tissues; tissue engineering and regenerative medicine |
| 04/21/2005 | US20050084876 Flip genes and flip proteins |
| 04/21/2005 | US20050084861 Methods of detecting modification of genetic material and monitoring processes thereof |
| 04/21/2005 | US20050084860 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/21/2005 | US20050084850 Stromal cell protein for use as tool in stimulating blood production in patients undergoing chemotherapy |
| 04/21/2005 | US20050084532 Contacting a polymer substrate with a plasticising fluid comprising a liquid or gaseous fluid in its natural or supercritical state to plasticize or swell the polymer to incorporate mammalian, plant and bacterial subcellular, cellular or multicellular matter, liposomes; drug delivery; surgery; grafting |
| 04/21/2005 | US20050084518 For producing beautiful skin and improving constipation, reducing hair loss |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084484 Administering Lactobacillus plantarum having catalase activity and superoxide dismutase activity as an antiinflammatory agent for rheumatic diseases and psoriasis |
| 04/21/2005 | US20050084482 As an antiinflammatory agent for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 04/21/2005 | US20050084479 Especially lactic acid bacteria as drug delivery devices in combination with edible carriers; tissue targeted therapy |
| 04/21/2005 | CA2542042A1 Antibody composition specifically binding to il-5 receptor |